What Dawn Health does
Dawn Health builds a platform and product suite of AI-enabled, connected health applications for pharmaceutical companies, including software-as-a-medical-device companion apps that support clinical trials, real-world evidence generation and patient engagement. The company says its platform combines AI, data and clinical integrations to help pharma teams launch digital products without rebuilding their technology foundation as regulatory requirements evolve. Dawn Health counts Merck and Novartis among its adopters. The company, a Trifork Labs portfolio company, is based in Copenhagen and has been developing its platform since 2021.
Dawn Health is a healthcare tool on Falcoscan. AI-enabled companion apps that connect pharma trials to patients. Falcoscan rates Dawn Health with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Dawn Health is founded in 2021, currently at Growth stage. Pricing: Paid.